1. Home
  2. QCOM vs NVO Comparison

QCOM vs NVO Comparison

Compare QCOM & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QUALCOMM Incorporated

QCOM

QUALCOMM Incorporated

N/A

Current Price

$138.29

Market Cap

148.9B

Sector

Technology

ML Signal

N/A

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

N/A

Current Price

$39.83

Market Cap

269.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QCOM
NVO
Founded
1985
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
148.9B
269.6B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
QCOM
NVO
Price
$138.29
$39.83
Analyst Decision
Buy
Hold
Analyst Count
20
11
Target Price
$170.89
$51.00
AVG Volume (30 Days)
8.5M
19.9M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
2.62%
3.19%
EPS Growth
N/A
N/A
EPS
2.78
N/A
Revenue
$44,284,000,000.00
N/A
Revenue This Year
$1.03
N/A
Revenue Next Year
$0.76
$4.39
P/E Ratio
$48.86
$13.60
Revenue Growth
13.66
N/A
52 Week Low
$120.80
$35.85
52 Week High
$205.55
$82.23

Technical Indicators

Market Signals
Indicator
QCOM
NVO
Relative Strength Index (RSI) 38.28 35.79
Support Level $132.73 N/A
Resistance Level $163.23 $50.30
Average True Range (ATR) 3.43 0.89
MACD 0.27 0.03
Stochastic Oscillator 32.86 28.36

Price Performance

Historical Comparison
QCOM
NVO

About QCOM QUALCOMM Incorporated

Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: